WRF
NVRO

Waddell & Reed Financial’s NEVRO CORP. NVRO Stock Holding History

Waddell & Reed Financial’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-480,285
Closed -$38.4M – 573
2018
Q2 		$38.4M Buy
480,285
+28,920
+6% +$2.4M 0.09% 254
2018
Q1 		$39.1M Buy
451,365
+22,470
+5% +$1.81M 0.09% 247
2017
Q4 		$29.6M Sell
428,895
-10,528
-2% -$842K 0.07% 285
2017
Q3 		$39.9M Sell
439,423
-38,376
-8% -$3.29M 0.09% 255
2017
Q2 		$35.6M Buy
477,799
+65,449
+16% +$5.24M 0.08% 278
2017
Q1 		$38.6M Sell
412,350
-70,430
-15% -$6.38M 0.08% 258
2016
Q4 		$35.1M Buy
482,780
+49,480
+11% +$4.24M 0.08% 264
2016
Q3 		$45.2M Hold
433,300
– – 0.09% 220
2016
Q2 		$32M Buy
433,300
+9,500
+2% +$645K 0.07% 258
2016
Q1 		$23.8M Buy
423,800
+163,600
+63% +$9.65M 0.04% 283
2015
Q4 		$17.6M Buy
260,200
+135,200
+108% +$7.24M 0.03% 335
2015
Q3 		$5.8M Buy
125,000
+53,200
+74% +$2.58M 0.01% 482
2015
Q2 		$3.86M Buy
+71,800
New +$3.66M 0.01% 536

Other funds holding NVRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Waddell & Reed Financial's NVRO Position: Q3 2018 in Review

Waddell & Reed Financial sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 480,285 shares — an estimated $38.4M sold.

Waddell & Reed Financial first reported a position in NVRO in Q2 2015 and held it in 13 quarters. The position peaked at $45.2M in Q3 2016. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • Waddell & Reed Financial reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • Waddell & Reed Financial sold 480,285 NEVRO CORP. shares in Q3 2018, an estimated $38.4M.
  • Waddell & Reed Financial first reported a position in NEVRO CORP. in Q2 2015 and held it in 13 quarters.
  • Waddell & Reed Financial's NEVRO CORP. position peaked at $45.2M in Q3 2016.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Waddell & Reed Financial's 13F filing for Q3 2018, filed 14 Nov 2018.